Ramanathan, Sudarshini
Al-Diwani, Adam
Waters, Patrick
Irani, Sarosh R. http://orcid.org/0000-0002-7667-9748
Funding for this research was provided by:
Wellcome Trust (104079/Z/14/Z)
British Medical Association (Vera Down)
BMA Foundation for Medical Research (Margaret Temple 2017)
BMA Foundation for Medical Research (Margaret Temple)
Article History
Received: 28 July 2019
Revised: 15 October 2019
Accepted: 17 October 2019
First Online: 26 October 2019
Compliance with ethical standards
:
: SR is the recipient of an National Health and Medical Research Council (Australia) Early Career Fellowship (APP1141169 - 2018), and has received research funding from the Petre Foundation (Australia), the Brain Foundation (Australia), and has served as a non-remunerated consultant on an advisory board for UCB. AAD is the recipient of a Wellcome Trust clinical research training fellowship (205126/Z/16/Z) and of a 2017 British Medical Association (BMA) Foundation Margaret Temple grant, and is supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and NIHR Oxford Health Biomedical Research Centre. SRI is supported by the Wellcome Trust (104079/Z/14/Z), the UCBOxford University Alliance, BMA Research Grants- Vera Down grant (2013) and Margaret Temple (2017) and Epilepsy Research UK (P1201). The research was funded /supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC; The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health). SRI is a coapplicant and receives royalties on patent application WO/2010/046716 (U.K. patent no., PCT/GB2009/051441) entitled 'Neurological Autoimmune Disorders'. The patent has been licensed to Euroimmun AG for the development of assays for LGI1 and other VGKC-complex antibodies. He has received honoraria from UCB, MedImmun, ADC therapeutics and Medlink Neurology. PW is a named inventor on patents for antibody assays and has received royalties. He has received honoraria from Biogen Idec, Mereo Biopharma, Retrogenix, UBC and Euroimmun AG; travel grants from the Guthy-Jackson Charitable Foundation; and research funding from Euroimmun AG.